Department of Physiology and Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
J Biol Chem. 2010 Nov 5;285(45):34566-78. doi: 10.1074/jbc.M110.165712. Epub 2010 Aug 24.
The small intestinal BB Na(+)/H(+) antiporter NHE3 accounts for the majority of intestinal sodium and water absorption. It is highly regulated with both postprandial inhibition and stimulation sequentially occurring. Phosphatidylinositide 4,5-bisphosphate (PI(4,5)P(2)) and phosphatidylinositide 3,4,5-trisphosphate (PI(3,4,5)P(3)) binding is involved with regulation of multiple transporters. We tested the hypothesis that phosphoinositides bind NHE3 under basal conditions and are necessary for its acute regulation. His(6) proteins were made from the NHE3 C-terminal region divided into four parts as follows: F1 (amino acids 475-589), F2 (amino acids 590-667), F3 (amino acids 668-747), and F4 (amino acids 748-832) and purified by a nickel column. Mutations were made in the F1 region of NHE3 and cloned in pet30a and pcDNA3.1 vectors. PI(4,5)P(2) and PI(3,4,5)P(3) bound only to the NHE3 F1 fusion protein (amino acids 475-589) on liposomal pulldown assays. Mutations were made in the putative lipid binding region of the F1 domain and studied for alterations in lipid binding and Na(+)/H(+) exchange as follows: Y501A/R503A/K505A; F509A/R511A/R512A; R511L/R512L; R520/FR527F; and R551L/R552L. Our results indicate the following. 1) The F1 domain of the NHE3 C terminus has phosphoinositide binding regions. 2) Mutations of these regions alter PI(4,5)P(2) and PI(3,4,5)P(3) binding and basal NHE3 activity. 3) The magnitude of serum stimulation of NHE3 correlates with PI(4,5)P(2) and PI(3,4,5)P(3) binding of NHE3. 4) Wortmannin inhibition of PI3K did not correlate with PI(4,5)P(2) or PI(3,4,5)P(3) binding of NHE3. Two functionally distinct phosphoinositide binding regions (Tyr(501)-Arg(512) and Arg(520)-Arg(552)) are present in the NHE3 F1 domain; both regions are important for serum stimulation, but they display differences in phosphoinositide binding, and the latter but not the former alters NHE3 surface expression.
小肠 BB Na(+)/H(+) 反向转运蛋白 NHE3 负责大部分肠道钠和水的吸收。它受到高度调节,先后发生餐后抑制和刺激。磷脂酰肌醇 4,5-二磷酸(PI(4,5)P(2)) 和磷脂酰肌醇 3,4,5-三磷酸(PI(3,4,5)P(3)) 的结合参与了多种转运蛋白的调节。我们检验了以下假设:在基础条件下,磷酸肌醇与 NHE3 结合,并对其急性调节是必要的。His(6) 蛋白由 NHE3 C 端区域分成四个部分制成:F1(氨基酸 475-589)、F2(氨基酸 590-667)、F3(氨基酸 668-747)和 F4(氨基酸 748-832),并通过镍柱进行纯化。在 NHE3 的 F1 区域进行突变,并在 pet30a 和 pcDNA3.1 载体中克隆。PI(4,5)P(2) 和 PI(3,4,5)P(3) 仅与脂质体下拉测定中的 NHE3 F1 融合蛋白(氨基酸 475-589)结合。在假定的 F1 结构域脂质结合区域进行突变,并研究脂质结合和 Na(+)/H(+) 交换的变化如下:Y501A/R503A/K505A;F509A/R511A/R512A;R511L/R512L;R520/FR527F;和 R551L/R552L。我们的结果表明:1)NHE3 C 端的 F1 结构域具有磷酸肌醇结合区域。2)这些区域的突变改变了 PI(4,5)P(2)和 PI(3,4,5)P(3)的结合和基础 NHE3 活性。3)血清刺激 NHE3 的幅度与 NHE3 的 PI(4,5)P(2)和 PI(3,4,5)P(3)结合相关。4)wortmannin 抑制 PI3K 与 NHE3 的 PI(4,5)P(2)或 PI(3,4,5)P(3)结合无关。NHE3 F1 结构域中存在两个具有不同功能的磷酸肌醇结合区域(Tyr(501)-Arg(512)和 Arg(520)-Arg(552));这两个区域对血清刺激都很重要,但它们在磷酸肌醇结合方面存在差异,后者而非前者改变 NHE3 的表面表达。